Intuitive Surgical Down 44%: Wall Street Eyes a Double-Your-Money Rebound Jul 28, 2026 Life Science, Technology
Bristol-Myers Squibb’s High Dividend Temporarily Backed by Financial Support, but Patent Cliff Poses Future Concerns Jul 25, 2026 Life Science
Tenet Healthcare Beats Q2 Expectations, Raises Full-Year Guidance, Sending Stock Up Over 17% Jul 25, 2026 Life Science
Eli Lilly and Intuitive Surgical Are Healthcare Stocks Worth Buying, Thanks to Strong Fundamentals Jul 24, 2026 Life Science
Intuitive Surgical’s Stock Has Fallen Over 25% This Year, but Goldman Sachs Still Recommends Investors Buy Jul 15, 2026 Life Science
Two Overhyped GLP-1 Stocks Present Buying Opportunities on Dips, with Novo Nordisk and Kailera Therapeutics Each Offering Unique Highlights Jul 14, 2026 Life Science
2026 Top Canadian Stock Investment Outlook, Dual-Track Positioning in Energy and Digital Health Jul 10, 2026 Life Science
Insiders Sell Nearly $900,000 in Stock as Monterosa Medical Faces Key Clinical Data Test Jun 29, 2026 Life Science
Merck KGaA’s $11.3 Billion Bio-Techne Buy Bolsters CGT Ambitions in Biggest Deal Since 2014 Jun 25, 2026 Life Science
